|
Khuri 356 (24): 2445, Table 1 June 14, 2007 |
| Return to Article | Add to Personal Archive | PowerPoint Help |

Adverse Outcomes Associated with Erythropoiesis-Stimulating Agents (ESA) Treatment in Patients with Cancer.
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |